Clinical and laboratory comparison of different brands of amphotericin B used for the treatment of Kala-azar: an observational study
Narayan, S.; Gupta, A.K.; Singh Subhankar, K.; Lal, C.S.; Singh, V.P.; Sinha, P.K.; Das, P.; Thakur, C.P.
Journal of Communicable Diseases 40(4): 273-276
2008
ISSN/ISBN: 0019-5138 PMID: 19579720 Document Number: 623203
The communication presents clinical response of cases of visceral leishmaniasis to treatment by two different brands of Amphotericin B. Fungizone was found to be slightly better than Amphotericin B, however, the difference is not statistically significant.
Document emailed within 1 workday
Related Documents
Mayrink, W.; Magalhàes, P.A.; Batista, S.M.; da Costa, C.A. 1971: Diagnosis of kala-azar. II. Study of Montenegro's test and detection of Leishmania in skin material from patients with kala-azar, before and after antimony treatment Revista do Instituto de Medicina Tropical de Sao Paulo 13(4): 268-271Mondal, D.; Hasnain, M.G.; Hossain, M.S.; Ghosh, D.; Ghosh, P.; Hossain, H.; Baker, J.; Nath, R.; Haque, R.; Matlashewski, G.; Hamano, S. 2016: Study on the safety and efficacy of miltefosine for the treatment of children and adolescents with post-kala-azar dermal leishmaniasis in Bangladesh, and an association of serum vitamin E and exposure to arsenic with post-kala-azar dermal leishmaniasis: an open clinical trial and case-control study protocol Bmj Open 6(5): E010050
Thakur, C.P.; Kumar, A.; Mitra, G.; Thakur, S.; Sinha, P.K.; Das, P.; Bhattacharya, S.K.; Sinha, A. 2008: Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India Indian Journal of Medical Research 128(1): 38-44
Sultana, A.; Zakaria, S.M.; Bhuiyan, S.I.; Habib, A.; Dey, S.K.; Rahman, M.; Basher, A. 2012: Spectrum of skin lesions of post-kala-azar dermal leishmaniasis in kala-azar endemic areas of Bangladesh Mymensingh Medical Journal: Mmj 21(3): 529-532
Sharma, V.K.; Jha, T.K. 1986: Recurrence of Kala-azar in a Case of Post Kala-azar Dermal Leishmaniasis Indian Journal of Dermatology Venereology and Leprology 52(1): 46-47
Thakur, C.P.; Sinha, G.P.; Sharma, V.; Barat, D. 1993: The treatment of kala-azar during pregnancy National Medical Journal of India 6(6): 263-265
Peters, W. 1981: The treatment of kala-azar--new approaches to an old problem Indian Journal of Medical Research 73(Suppl): 1-18
Laroche, R.; Sirol, J.; Poli, L. 1978: Treatment of visceral leishmaniasis or kala-azar Medecine Tropicale: Revue du Corps de Sante Colonial 38(4): 401-404
Wu, Z.; Bao, Y.; Ding, Y.; Yu, M.; Lu, L.; Zhang, Y. 1997: An experimental study on application of PCR in detection of kala-azar Southeast Asian Journal of Tropical Medicine and Public Health 28(1): 169-172
Sundar, S.; Murray, H.W. 2005: Availability of miltefosine for the treatment of kala-azar in India Bulletin of the World Health Organization 83(5): 394-395
Nyakundi, P.M.; Rashid, J.R.; Wasunna, K.M.; Were, J.B.; Muigai, R.; Kirigi, G.; Mbugua, J. 1995: Problems in the treatment of kala-azar: case report East African Medical Journal 72(6): 406-408
Karki, P.; Koirala, S.; Parija, S.C.; Hansdak, S.G.; Das, M.L. 1998: A thirty day course of sodium stibogluconate for treatment of Kala-azar in Nepal Southeast Asian Journal of Tropical Medicine and Public Health 29(1): 154-158
Sundar, S. 2003: Indian kala-azar--better tools needed for diagnosis and treatment Journal of Postgraduate Medicine 49(1): 29-30
Hörder, M.; Vanek, E.; Heymer, B. 1979: Kala-azar acquired in Europe: a case report with particular consideration of its epidemiology and treatment Die Medizinische Welt 30(8): 280-284
Murray, H.W. 2000: Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 4(3): 158-177
Marwaha, N.; Sarode, R.; Gupta, R.K.; Garewal, G.; Dash, S. 1991: Clinico-hematological characteristics in patients with kala azar. a study from north-west India Tropical and Geographical Medicine 43(4): 357-362
Skouri, H.; Gandouz, R.; Kraiem, I.; Harrabi, I.; Ben Said, M. 2008: Antibodies to anionic phospholipids and cofactors in kala-azar. Comparative study with malaria, toxoplasmosis and "autoimmune diseases" Clinical and Experimental Rheumatology 26(5): 894-902
DE Brito, T.; Hoshino-Shimizu, S.; Neto, V.A.; Duarte, I.S.; Penna, D.O. 1975: Glomerular involvement in human kala-azar. a light, immunofluorescent, and electron microscopic study based on kidney biopsies American Journal of Tropical Medicine and Hygiene 24(1): 9-18
Salam, M.A.; Siddiqui, M.A.; Nabi, S.G.; Bhaskar, K.R.H.; Mondal, D. 2013: Post-kala-azar dermal leishmaniasis with mucosal involvement: an unusual case presentation including successful treatment with miltefosine Journal of Health Population and Nutrition 31(2): 294-297
Singh S; Kumar, J.; Singh, R.; Dwivedi, S.N. 2000: Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable anti-leishmanial drugs: a community-based study International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 4(4): 203-208